Table 1 The comparison results of demographic data, prior medical history, and medication use history between the CSFP group and the non-CSFP group
From: Comparison of TyG and modified TyG indices in predicting coronary slow flow phenomenon
Variables | Non-CSFP group (n = 586) | CSFP group (n = 69) | Statistic | P |
|---|---|---|---|---|
Age, years, M (Q₁, Q₃) | 64.00 (57.00, 70.75) | 64.00 (57.00, 69.00) | Z=-0.77 | 0.439 |
BMI, kg/m2,M (Q₁, Q₃) | 25.56 (23.11, 27.68) | 26.56 (25.35, 28.72) | Z=-3.32 | < 0.001 |
Gender, n(%) | χ²=0.93 | 0.335 | ||
Female | 204 (34.81) | 20 (28.99) | ||
Male | 382 (65.19) | 49 (71.01) | ||
Hypertension, n(%) | χ²=0.37 | 0.544 | ||
No | 191 (32.59) | 20 (28.99) | ||
Yes | 395 (67.41) | 49 (71.01) | ||
Diabetes melittus, n(%) | χ²=2.68 | 0.102 | ||
No | 348 (59.39) | 48 (69.57) | ||
Yes | 238 (40.61) | 21 (30.43) | ||
Dyslipidemia, n(%) | χ²=0.66 | 0.415 | ||
No | 184 (31.40) | 25 (36.23) | ||
Yes | 402 (68.60) | 44 (63.77) | ||
Previous stroke, n(%) | χ²=1.22 | 0.269 | ||
No | 482 (82.25) | 53 (76.81) | ||
Yes | 104 (17.75) | 16 (23.19) | ||
Previous CAD, n(%) | χ²=2.10 | 0.147 | ||
No | 497 (84.81) | 63 (91.30) | ||
Yes | 89 (15.19) | 6 (8.70) | ||
Chronic kidney disease, n(%) | χ²=12.63 | < 0.001 | ||
No | 467 (79.69) | 42 (60.87) | ||
Yes | 119 (20.31) | 27 (39.13) | ||
Current smoker, n(%) | χ²=0.04 | 0.845 | ||
No | 341 (58.19) | 41 (59.42) | ||
Yes | 245 (41.81) | 28 (40.58) | ||
Anti-platelet therapy, n(%) | - | 0.495 | ||
No | 237 (40.27) | 24 (34.78) | ||
Yes | 349 (59.56) | 45 (65.22) | ||
Nitrogen, n(%) | χ²=0.04 | 0.850 | ||
No | 372 (63.48) | 43 (62.32) | ||
Yes | 214 (36.52) | 26 (37.68) | ||
RASSi, n(%) | χ²=0.49 | 0.482 | ||
No | 348 (59.39) | 44 (63.77) | ||
Yes | 238 (40.61) | 25 (36.23) | ||
Beta blocker, n(%) | χ²=0.00 | 0.952 | ||
No | 278 (47.44) | 33 (47.83) | ||
Yes | 308 (52.56) | 36 (52.17) | ||
CCB, n(%) | χ²=0.77 | 0.380 | ||
No | 396 (67.58) | 43 (62.32) | ||
Yes | 190 (32.42) | 26 (37.68) | ||
Anti-diabetic therapy, n(%) | χ²=5.15 | 0.023 | ||
No | 427 (72.87) | 59 (85.51) | ||
Yes | 159 (27.13) | 10 (14.49) |